American Lung Association, FNIH cancer news

ALA partnered with FNIH to promote the Phase II/III Lung-MAP trial, a master protocol trial designed to evaluate several compounds simultaneously to treat squamous cell lung cancer. ALA will promote the study through its Lung Force website, produce videos for investigators and patients and sponsor meetings that include Lung-MAP leadership. ...